Wegovy dosing: every step on the FDA label, and what each dose costs

Wegovy injection

Starting dose

• Injection starting dose 0.25 mg once weekly. The recommended starting dosage of WEGOVY injection is 0.25 mg administered subcutaneously once weekly.dailymed.nlm.nih.gov, Sep 27, 2026

Stepping up

• Table 1. Recommended Starting Dosage and Dosage Escalation of WEGOVY Injection for All Approved Indications in Adults and Pediatric Patients Aged 12 Years and Older dailymed.nlm.nih.gov, Sep 27, 2026
• Weeks Once-weekly Subcutaneous Injection Dosage dailymed.nlm.nih.gov, Sep 27, 2026
• Weeks 1-4: 0.25 mg. Starting Dosage 1 through 4 0.25 mgdailymed.nlm.nih.gov, Sep 27, 2026
• Weeks 5-8: 0.5 mg. Dosage Escalation 5 through 8 0.5 mgdailymed.nlm.nih.gov, Sep 27, 2026
• Weeks 9-12: 1 mg. 9 through 12 1 mgdailymed.nlm.nih.gov, Sep 27, 2026
• Weeks 13-16: 1.7 mg. 13 through 16 1.7 mgdailymed.nlm.nih.gov, Sep 27, 2026
• Week 17 onward: maintenance dose by indication. Maintenance Dosage 17 and onward See the indication below for the recommended maintenance dosage(s)dailymed.nlm.nih.gov, Sep 27, 2026
• If a step is not tolerated, consider delaying escalation 4 weeks. If patients do not tolerate a dose during dosage escalation, consider delaying dosage escalation for 4 weeks.dailymed.nlm.nih.gov, Sep 27, 2026

Maintenance and maximum dose

• Adult weight-reduction maintenance: 1.7 mg or 2.4 mg (recommended) weekly. The maintenance dosage of WEGOVY for weight reduction in adults is either 1.7 mg or 2.4 mg (recommended) injected subcutaneously once weekly.dailymed.nlm.nih.gov, Sep 27, 2026
• Optional increase to a maximum of 7.2 mg weekly after tolerating 2.4 mg for at least 4 weeks. For patients who tolerate the 2.4 mg dosage for at least 4 weeks and additional weight reduction is clinically indicated, the dosage may be increased to a maximum dosage of 7.2 mg subcutaneously once weekly.dailymed.nlm.nih.gov, Sep 27, 2026
• Pediatric (12+) weight-reduction maintenance: 2.4 mg (recommended) or 1.7 mg. The maintenance dosage of WEGOVY injection for weight reduction in pediatric patients aged 12 years and older is either 2.4 mg (recommended), or 1.7 mg once weekly.dailymed.nlm.nih.gov, Sep 27, 2026
• CV risk reduction maintenance: 2.4 mg (recommended) or 1.7 mg. The maintenance dosage of WEGOVY injection for cardiovascular risk reduction in adults is either 2.4 mg (recommended) or 1.7 mg once weekly.dailymed.nlm.nih.gov, Sep 27, 2026

If you miss a dose

• If one dose of WEGOVY injection is missed and the next scheduled dose is: dailymed.nlm.nih.gov, Sep 27, 2026
• Next dose more than 2 days away: inject as soon as possible. more than 2 days away, administer WEGOVY injection as soon as possible.dailymed.nlm.nih.gov, Sep 27, 2026
• Next dose less than 2 days away: skip and resume on the usual day. less than 2 days away, do not administer the WEGOVY injection dose. Resume dosing on the regularly scheduled day of the week.dailymed.nlm.nih.gov, Sep 27, 2026

After several missed doses

• 2 or more consecutive missed doses: restart escalation at a lower dose. If 2 or more consecutive doses of WEGOVY injection are missed, reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactionsdailymed.nlm.nih.gov, Sep 27, 2026

Switching between forms

• Tablets to injection: allowed. Patients may switch from WEGOVY 25 mg tablets to WEGOVY injection.dailymed.nlm.nih.gov, Sep 27, 2026
• Tablets to injection: start 2.4 mg weekly the day after the last 25 mg tablet (1.7 mg if tablets not tolerated). The day after discontinuing WEGOVY tablets 25 mg once daily, initiate WEGOVY 2.4 mg subcutaneous injection once weekly. For patients who do not tolerate WEGOVY 25 mg tablets, consider switching to WEGOVY 1.7 mg injection.dailymed.nlm.nih.gov, Sep 27, 2026

How it comes

• WEGOVY injection is a clear, colorless solution available in cartons containing 4 single-dose pens, 4 single-dose syringes with integrated needles, or 1 single-patient-use pen (WEGOVY FlexTouch) as follows: dailymed.nlm.nih.gov, Sep 27, 2026
• Single-dose pen strengths incl. 7.2 mg (WEGOVY HD). 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, 2.4 mg/0.75 mL, or 7.2 mg/0.75 mL (WEGOVY HD) in a single-dose pendailymed.nlm.nih.gov, Sep 27, 2026
• Single-dose syringe strengths. 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, or 2.4 mg/0.75 mL in a single-dose syringedailymed.nlm.nih.gov, Sep 27, 2026
• WEGOVY FlexTouch: one pen with four 2.4 mg doses. 9.6 mg/3 mL (3.2 mg/mL) solution in a single-patient-use pen (WEGOVY FlexTouch) that delivers four 2.4 mg/0.75 mL dosesdailymed.nlm.nih.gov, Sep 27, 2026
• FlexTouch carton row (NDC). Single-patient-use Pen (with 4 weekly doses of 2.4 mg) WEGOVY FlexTouch 9.6 mg/3 mL (3.2 mg/mL) 0169-4915-32dailymed.nlm.nih.gov, Sep 27, 2026
• WEGOVY HD 7.2 mg pen row (NDC). Single-dose Pen WEGOVY HD 7.2 mg/0.75 mL 0169-4572-14dailymed.nlm.nih.gov, Sep 27, 2026

Label revised 6/2026: full label on DailyMed.

Wegovy tablets

Starting dose

• Tablets starting dose 1.5 mg once daily. The recommended starting dosage of WEGOVY tablets is 1.5 mg taken orally once daily.dailymed.nlm.nih.gov, Sep 27, 2026

Stepping up

• Table 2. Recommended Dosage of WEGOVY Tablets for Cardiovascular Risk Reduction or Weight Reduction in Adults dailymed.nlm.nih.gov, Sep 27, 2026
• Days Once Daily Tablet Dosage dailymed.nlm.nih.gov, Sep 27, 2026
• Days 1-30: 1.5 mg. Starting Dosage 1 through 30 1.5 mgdailymed.nlm.nih.gov, Sep 27, 2026
• Days 31-60: 4 mg. Dosage Escalation 31 through 60 4 mgdailymed.nlm.nih.gov, Sep 27, 2026
• Days 61-90: 9 mg. 61 through 90 9 mgdailymed.nlm.nih.gov, Sep 27, 2026
• Day 91 onward: 25 mg. Maintenance Dosage 91 and onward 25 mgdailymed.nlm.nih.gov, Sep 27, 2026
• If a step is not tolerated, consider delaying escalation. If patients do not tolerate a dose during dosage escalation, consider delaying dosage escalation.dailymed.nlm.nih.gov, Sep 27, 2026

Maintenance and maximum dose

• Tablets maintenance 25 mg once daily. The recommended maintenance dosage of WEGOVY tablets is 25 mg orally once daily.dailymed.nlm.nih.gov, Sep 27, 2026
• If 25 mg not tolerated, consider switching to injection 1.7 mg weekly. If patients do not tolerate the 25 mg once daily maintenance dosage, consider switching to WEGOVY injection 1.7 mg once weekly [see Dosage and Administration (2.5)].dailymed.nlm.nih.gov, Sep 27, 2026

If you miss a dose

• Missed tablet: skip it and take the next dose the following day. If a dose of WEGOVY tablets is missed, skip the missed dose and take the next dose the following day.dailymed.nlm.nih.gov, Sep 27, 2026

Switching between forms

• Injection to tablets: allowed from 2.4 mg injection. Patients taking WEGOVY 2.4 mg injection for cardiovascular risk reduction or weight reduction in adults may switch to WEGOVY 25 mg tablets.dailymed.nlm.nih.gov, Sep 27, 2026
• Injection to tablets: start 25 mg daily one week after the last 2.4 mg injection. One week after discontinuing WEGOVY 2.4 mg injection, initiate 25 mg of WEGOVY tablets orally once daily.dailymed.nlm.nih.gov, Sep 27, 2026
• Type 2 diabetes: inadequate response on tablets, consider switching to injection. In patients with type 2 diabetes with an inadequate response to WEGOVY tablets, consider alternative therapies, including switching to WEGOVY injection [see Dosage and Administration (2.5)].dailymed.nlm.nih.gov, Sep 27, 2026

How it comes

• Tablet strengths. Tablets: 1.5 mg, 4 mg, 9 mg and 25 mg (3)dailymed.nlm.nih.gov, Sep 27, 2026
• 1.5 mg: bottle of 30 tablets (NDC). 1.5 mg White to light yellow, round shaped debossed with “1.5” on one side and “novo” on the other side Bottle of 30 tablets 0169-4415-31dailymed.nlm.nih.gov, Sep 27, 2026
• 4 mg: bottle of 30 tablets (NDC). 4 mg White to light yellow, round shaped debossed with “4” on one side and “novo” on the other side Bottle of 30 tablets 0169-4404-31dailymed.nlm.nih.gov, Sep 27, 2026
• 9 mg: bottle of 30 tablets (NDC). 9 mg White to light yellow, round shaped debossed with “9” on one side and “novo” on the other side Bottle of 30 tablets 0169-4409-31dailymed.nlm.nih.gov, Sep 27, 2026
• 25 mg: bottle of 30 tablets (NDC). 25 mg White to light yellow, oval shaped debossed with “25” on one side and “novo” on the other side Bottle of 30 tablets 0169-4425-31dailymed.nlm.nih.gov, Sep 27, 2026

Label revised 6/2026: full label on DailyMed.

What each dose costs, self-pay

52-week totals and every place to buy it: Wegovy cost.